Svane, I. M., Nikolajsen, K., & Johnsen, H. E. (2007). Antigen-Specific T-Cell Immunity in Multiple Myeloma Patients is Restored Following High-Dose Therapy: Implications for Timing of Vaccination. Scandinavian Journal of Immunology, 66(4), 465. https://doi.org/10.1111/j.1365-3083.2007.01993.x
Chicago Style (17th ed.) CitationSvane, I. M., K. Nikolajsen, and H. E. Johnsen. "Antigen-Specific T-Cell Immunity in Multiple Myeloma Patients Is Restored Following High-Dose Therapy: Implications for Timing of Vaccination." Scandinavian Journal of Immunology 66, no. 4 (2007): 465. https://doi.org/10.1111/j.1365-3083.2007.01993.x.
MLA (9th ed.) CitationSvane, I. M., et al. "Antigen-Specific T-Cell Immunity in Multiple Myeloma Patients Is Restored Following High-Dose Therapy: Implications for Timing of Vaccination." Scandinavian Journal of Immunology, vol. 66, no. 4, 2007, p. 465, https://doi.org/10.1111/j.1365-3083.2007.01993.x.